Innoveren Scientific, Inc.
IVRN
Revenue
73.90k
▼-305.66k▼-80.53%
3 Months ChangeAssets
789.32k
▲581.19k▲279.26%
3 Months ChangeLiabilities
11.68M
▲1.04M▲9.73%
3 Months ChangeFree Cash Flow
-1.31M
▲2.57M▲66.30%
24 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-08-15
Form 8-K
ID: 0001493152-24-032596
2024-07-02
Form 8-K
ID: 0001493152-24-026053
2024-06-25
Form 8-K
ID: 0001493152-24-025094
2024-06-11
Form 8-K
ID: 0001493152-24-023425
2024-05-22
Form 8-K
ID: 0001493152-24-020986
2024-04-01
Form 8-K
ID: 0001493152-24-012228
2024-03-06
Form 8-K
ID: 0001493152-24-008948
2024-02-28
Form 8-K
ID: 0001493152-24-008223
2023-12-21
Form 8-K
ID: 0001493152-23-045759
2023-11-15
Form 10-Q
ID: 0001493152-23-041399